Skip to search.
 TSX Down0.80% TSX Ventures 0.00%

Anika Therapeutics Inc. (ANIK)

-NasdaqGS

17.54 Down 0.01(0.06%) 4:00PM EDT|After Hours : 17.54 0.00 (0.00%) 4:32PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending2012-12-302011-12-302010-12-30
Total Revenue 71,359   64,779   55,557  
Cost of Revenue28,989  26,784  23,827  
Gross Profit 42,370   37,995   31,730  
Operating Expenses
Research Development5,388  6,169  6,875  
Selling General and Administrative14,729  17,859  17,318  
Non Recurring2,538   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 19,715   13,967   7,538  
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -  
Earnings Before Interest And Taxes19,527  13,785  7,343  
Interest Expense -   -   -  
Income Before Tax19,527  13,785  7,343  
Income Tax Expense7,770  5,318  3,027  
Minority Interest -   -   -  
Net Income From Continuing Ops11,757  8,467  4,316  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 11,757   8,467   4,316  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 11,757   8,467   4,316  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.